nash tirzepatide phase 2 for the treatment of metabolic dysfunction-associated steatohepatitis with liver fibrosis: results of the SYNERGY-NASH trial Brenipatide vs Tirzepatide: 2026 Comparison – Tirzepatide: A Game-Changer for MASH

Glucose levels are associated with mood, but the association is mediated by ratings of metabolic state

Combined GHRH + GHRP/ghrelin-mimetic administration has produced larger, amplified GH pulses than either agent alone in human secretagogue studies

Safety data is similarly limited, with the tolerability of creams and long-term effects sparsely analyzed in the literature

GLP-1 RA Use Improves Disease Activity, Cardiovascular Risk in Rheumatoid Arthritis Abigail Brooks, MA Ryan Livingston Key Takeaways GLP-1 RAs may reduce RA disease activity, pain, and cardiovascular risk factors in patients with RA and obesity

Administration discipline The commonly described route in dosage guides is subcutaneous injection , and that matters because route changes can alter how a protocol behaves in practice

The effect of glucagon like peptide-1 receptor agonist on behavioral despair and anxiety-like behavior in ovariectomized rats: modulation of BDNF/CREB, Nrf2 and lipocalin 2